Tradestie Institutional Equity Comparison Engine

ABCL vs SDG โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ABCL Overall Edge

ABCL Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to AbCellera Biologics Inc. Common Shares (ABCL) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ABCL trades at 27.6x Forward P/E with -1550.0% operating margin (-76.3% YoY revenue) versus SDG at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ABCL sits in CONSOLIDATION (29th %ile IV; Dealer Gamma Walls on Pro) against SDG sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ABCL
ABCL 27.6x vs SDG N/M Fwd P/E
Growth & Margin Winner ABCL
Op Margin -1550.0% vs N/A ยท YoY -76.3% vs N/A
Momentum & Technical Winner ABCL
1Y +207.2% vs +0.1% ยท 52W Pos 68% vs 38%
Options & Structure Winner ABCL
CONSOLIDATION (29th %ile IV) vs UNCLASSIFIED (N/A IV)
ABCL NASDAQ
AbCellera Biologics Inc. Common Shares
Pharmaceutical Preparations
$11.12
-3.22% 1D
Market Cap $3.8B
1M Return -5.76%
1Y Return +207.18%
Forward P/E 27.6x
Unified AI Score
63.5 / 100 BUY
Tech 57.0 Fund 59.0 Flow 67.0 Mom 54.0
SDG NASDAQ
iShares Trust iShares MSCI Global Sustainable Development Goals ETF
Institutional Equity
$85.63
-0.81% 1D
Market Cap N/A
1M Return -0.31%
1Y Return +0.06%
Forward P/E N/M
Unified AI Score
45.9 / 100 HOLD
Tech 38.0 Fund 50.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ABCL +207.18% SDG +0.06% Spread: +207.12 pp (ABCL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ABCL TTM Op. Margin: -1550.0% SDG TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABCL vs SDG. Trailing 12-month operating profitability (ABCL -1550.0% vs SDG N/A) and valuation multiples (ABCL 27.6x vs SDG N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ABCL (9) vs SDG (1)
Institutional Metric ABCL SDG Criterion Row Winner
Market Capitalization Scale $3.8B N/A Larger Scale ABCL
Trailing P/E Ratio Valuation 27.6x N/M Lower Multiple ABCL
Forward P/E Ratio Valuation 27.6x N/M Lower Multiple ABCL
Revenue Growth (YoY) Growth -76.3% N/A Higher Growth ABCL
Operating Margin (TTM) Profitability -1550.0% N/A Higher Margin ABCL
Net Profit Margin Profitability -248.8% N/A Higher Margin ABCL
Return on Equity (ROE) Capital Efficiency -17.3% N/A Higher ROE ABCL
52-Week Range Position Momentum 68% ($3โ€“$15) 38% ($80โ€“$94) Stronger Trend ABCL
Beta / 30D Volatility Risk Regime 2.30ฮฒ ยท 87% Vol 0.84ฮฒ ยท 15% Vol Lower Realized Risk SDG
Unified Institutional Score Composite Signal 63.5 / 100 (BUY) 45.9 / 100 (HOLD) Higher Composite ABCL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ABCL vs SDG Buy Guide
ABCL CONSOLIDATION
34d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 29th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ABCL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SDG UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SDG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ABCL nor SDG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.